Literature DB >> 2556844

Expression of the peplomer glycoprotein of murine coronavirus JHM using a baculovirus vector.

S Yoden1, T Kikuchi, S G Siddell, F Taguchi.   

Abstract

The gene encoding the E2 peplomer glycoprotein of coronavirus mouse hepatitis virus JHM strain (JHMV) has been inserted into the genome of Autographa californica nuclear polyhedrosis baculovirus (AcNPV) in lieu of the coding region of the AcNPV polyhedrin gene. This recombinant virus produced E2 protein in insect cells under the control of the baculovirus polyhedrin promotor. The expressed E2 protein was shown in size and antigenic properties to be similar to the E2 protein produced in mouse cells infected by JHMV. The expressed E2 protein was glycosylated and transported to the cell surface; however, no proteolytic cleavage was detected in insect cells. The sera from rats immunized with partially purified E2 protein derived from insect cells reacted in immunoprecipitation and immunofluorescence experiments with the E2 protein produced in JHMV-infected mouse cells. The antiserum failed to neutralize the infectivity of JHMV. These results suggest that the E2 protein expressed by the recombinant baculovirus in insect cells is similar but not identical to the E2 protein produced in JHMV-infected mouse cells. The inability of the E2 protein expressed in insect cells to produce neutralizing antibody is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556844      PMCID: PMC7131197          DOI: 10.1016/0042-6822(89)90573-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus.

Authors:  K L van Wyke Coelingh; B R Murphy; P L Collins; A M Lebacq-Verheyden; J F Battey
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

2.  Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages.

Authors:  F Taguchi; A Yamada; K Fujiwara
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

3.  Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2).

Authors:  H Wege; R Dörries; H Wege
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

4.  Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM.

Authors:  I Schmidt; M Skinner; S Siddell
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

5.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

6.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion.

Authors:  M F Frana; J N Behnke; L S Sturman; K V Holmes
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments.

Authors:  L S Sturman; C S Ricard; K V Holmes
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

8.  Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.

Authors:  J O Fleming; S A Stohlman; R C Harmon; M M Lai; J A Frelinger; L P Weiner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels.

Authors:  L S Sturman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

10.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

View more
  6 in total

1.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

2.  Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; T J Zamb; J V van den Hurk; M Campos; R Harland; L A Babiuk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Analysis of the S spike (peplomer) glycoprotein of bovine coronavirus synthesized in insect cells.

Authors:  D Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

4.  Structural, functional, and immunological characterization of bovine herpesvirus-1 glycoprotein gl expressed by recombinant baculovirus.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; J V van den Hurk; M Campos; L A Babiuk; T Zamb
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

5.  Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein.

Authors:  S Takase-Yoden; T Kikuchi; S G Siddell; F Taguchi
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

6.  Characterization of haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed by a recombinant baculovirus.

Authors:  M Niikura; Y Matsuura; M Hattori; M Onuma; T Mikami
Journal:  Virus Res       Date:  1991-06       Impact factor: 3.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.